we conducted a population-based case-control study, which included 365 oesophageal adenocarcinoma (oac), 426 oesophagogastric junction adenocarcinoma (ogjac) and 303 oesophageal squamous cell carcinoma (oscc) cases, with frequency matched on age, sex and geographical location to 1580 controls.